Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin/Benzoyl Peroxide Gel versus DUAC Akne Gel versus Vehicle in Papulopustular Acne
2017-000522-36Phase 3Completed
- Sponsor
- Dermapharm
- Start
- Apr 2018
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clindamycin + benzoyl peroxide in acne papulopustulosa and acne vulgaris (3 arms), sponsored by Dermapharm. Primary endpoints: Percent change in inflammatory lesion count and Percent change in total lesion count. Started Apr 2018; status: completed.
02
Drugs
clindamycin + benzoyl peroxide
03
Conditions
acne papulopustulosaacne vulgaris
Beyond the preview
Go deeper on 2017-000522-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000522-36.